Advisory Services Network’s Corbus Pharmaceuticals CRBP Stock Holding History

Advisory Services Network’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$131	Buy	+14	New	+$118	﹤0.01%	4642
2025 Q4	–	Sell	-14	Closed	-$177	–	2316
2025 Q3	$177	Buy	+14	New	+$133	﹤0.01%	4236
2021 Q1	–	Sell	-233	Closed	-$9K	–	1609
2020 Q4	$9K	Buy	233 +200	+606%	+$7.48K	﹤0.01%	2467
2020 Q3	$2K	Buy	+33	New	+$5.98K	﹤0.01%	3085

Other funds holding CRBP

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Advisory Services Network's CRBP Position: Q1 2026 in Review

Advisory Services Network opened a new position in Corbus Pharmaceuticals (CRBP) in Q1 2026: 14 shares worth $131. The stake represents ﹤0.01% of the portfolio and ranks #4642 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in CRBP as recently as Q3 2025.

Advisory Services Network first reported a position in CRBP in Q3 2020 and has held it in 4 quarters since. The position peaked at $9K in Q4 2020. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.

Advisory Services Network held 14 shares of Corbus Pharmaceuticals worth $131 as of Q1 2026.
Corbus Pharmaceuticals was a new Advisory Services Network position in Q1 2026.
Corbus Pharmaceuticals made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #4642 holding.
Advisory Services Network first reported a position in Corbus Pharmaceuticals in Q3 2020 and has held it in 4 quarters since.
Advisory Services Network's Corbus Pharmaceuticals position peaked at $9K in Q4 2020.
107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.